ChloroquineV1, Istex, Corpus, bibRecord, 002C47

New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii

Identifieur interne : 002C47 ( Istex/Corpus ); précédent : 002C46; suivant : 002C48

New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii

Auteurs : Sherry F. Queener

Source :

Journal of Medicinal Chemistry [ 0022-2623 ] ; 2002.

RBID : ISTEX:5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22
Url:

https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/fulltext.pdf

DOI: 10.1021/jm00024a001

Links to Exploration step

ISTEX:5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</title>
<author><name sortKey="Queener, Sherry F" sort="Queener, Sherry F" uniqKey="Queener S" first="Sherry F." last="Queener">Sherry F. Queener</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22</idno>
<date when="1995-11-01" year="1995">1995-11-01</date>
<idno type="doi">10.1021/jm00024a001</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C47</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002C47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</title>
<author><name sortKey="Queener, Sherry F" sort="Queener, Sherry F" uniqKey="Queener S" first="Sherry F." last="Queener">Sherry F. Queener</name>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Medicinal Chemistry</title>
<title level="j" type="abbrev">J. Med. Chem.</title>
<imprint><publisher>American Chemical Society</publisher>
<date type="e-published" when="2002-05-01">2002</date>
<date when="1995-11-01">1995</date>
<biblScope unit="vol">38</biblScope>
<biblScope unit="issue">24</biblScope>
<biblScope unit="page" from="4739">4739</biblScope>
<biblScope unit="page" to="4759">4759</biblScope>
</imprint>
<idno type="ISSN">0022-2623</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>acs</corpusName>
<keywords><teeft><json:string>carinii</json:string>
<json:string>pneumocystis</json:string>
<json:string>dihydrofolate</json:string>
<json:string>reductase</json:string>
<json:string>pentamidine</json:string>
<json:string>chemother</json:string>
<json:string>antimicrob</json:string>
<json:string>agent chemother</json:string>
<json:string>carinii pneumonia</json:string>
<json:string>pneumocystis carinii</json:string>
<json:string>carinii dihydrofolate reductase</json:string>
<json:string>analogue</json:string>
<json:string>antipneumocystis</json:string>
<json:string>pyrimethamine</json:string>
<json:string>queener</json:string>
<json:string>pneumocystis carinii pneumonia</json:string>
<json:string>primaquine</json:string>
<json:string>prophylaxis</json:string>
<json:string>trimethoprim</json:string>
<json:string>atovaquone</json:string>
<json:string>medicinal chemistry</json:string>
<json:string>cyst</json:string>
<json:string>methotrexate</json:string>
<json:string>epiroprim</json:string>
<json:string>selectivity</json:string>
<json:string>antipneumocystis activity</json:string>
<json:string>cycloguanil</json:string>
<json:string>pneumonia</json:string>
<json:string>dihydropteroate</json:string>
<json:string>substituents</json:string>
<json:string>antifungal</json:string>
<json:string>chem</json:string>
<json:string>folate</json:string>
<json:string>immunodeficiency</json:string>
<json:string>sulfamethoxazole</json:string>
<json:string>dapsone</json:string>
<json:string>dihydrofolate reductase</json:string>
<json:string>phenyl</json:string>
<json:string>tidwell</json:string>
<json:string>animal model</json:string>
<json:string>toxicity</json:string>
<json:string>och3</json:string>
<json:string>piritrexim</json:string>
<json:string>trimetrexate</json:string>
<json:string>topoisomerase</json:string>
<json:string>inosine</json:string>
<json:string>diamidines</json:string>
<json:string>analog</json:string>
<json:string>walzer</json:string>
<json:string>dos</json:string>
<json:string>diamidine</json:string>
<json:string>butamidine</json:string>
<json:string>aid patient</json:string>
<json:string>gondii</json:string>
<json:string>antifolates</json:string>
<json:string>toxoplasma</json:string>
<json:string>dipp</json:string>
<json:string>isomer</json:string>
<json:string>immunosuppressed</json:string>
<json:string>sulfonamide</json:string>
<json:string>pharmacokinetics</json:string>
<json:string>medicinal</json:string>
<json:string>antimalarial</json:string>
<json:string>para</json:string>
<json:string>inoculated</json:string>
<json:string>benzimidazoles</json:string>
<json:string>albendazole</json:string>
<json:string>phenyl ring</json:string>
<json:string>amphotericin</json:string>
<json:string>deferoxamine</json:string>
<json:string>immune</json:string>
<json:string>synthase</json:string>
<json:string>dfmo</json:string>
<json:string>meta</json:string>
<json:string>kovacs</json:string>
<json:string>toxoplasma gondii</json:string>
<json:string>diimidazoline</json:string>
<json:string>lamblia</json:string>
<json:string>gavage</json:string>
<json:string>synthetase</json:string>
<json:string>propamidine</json:string>
<json:string>dimp</json:string>
<json:string>inhibitor</json:string>
<json:string>biochem</json:string>
<json:string>dekker</json:string>
<json:string>cyst count</json:string>
<json:string>biol</json:string>
<json:string>carinii growth</json:string>
<json:string>sterol</json:string>
<json:string>less active</json:string>
<json:string>immunodeficiency syndrome</json:string>
<json:string>micromolar</json:string>
<json:string>giardia</json:string>
<json:string>alkaloid</json:string>
<json:string>giardia lamblia</json:string>
<json:string>pneumonitis</json:string>
<json:string>topoisomerases</json:string>
<json:string>therapy model</json:string>
<json:string>purine</json:string>
<json:string>marcel dekker</json:string>
<json:string>naphthyl</json:string>
<json:string>pyrimidine</json:string>
<json:string>compound</json:string>
<json:string>more potent</json:string>
<json:string>acridone alkaloid</json:string>
<json:string>pentamidine analogue</json:string>
<json:string>meta position</json:string>
<json:string>carinii enzyme</json:string>
<json:string>trans isomer</json:string>
<json:string>assay</json:string>
<json:string>fungal</json:string>
<json:string>more active</json:string>
<json:string>carinii infection</json:string>
<json:string>significant activity</json:string>
<json:string>experimental pneumocystis carinii pneumonia</json:string>
<json:string>pneumocystis carinii dihydrofolate reductase</json:string>
<json:string>antifungal agent</json:string>
<json:string>human immunodeficiency virus infection</json:string>
<json:string>selectivity ratio</json:string>
<json:string>calf thymus</json:string>
<json:string>culture model</json:string>
<json:string>perspective chart</json:string>
<json:string>pneumocystis pneumonia</json:string>
<json:string>dihydropteroate synthase</json:string>
<json:string>substitution</json:string>
<json:string>amino</json:string>
<json:string>derivative</json:string>
<json:string>active diimidazoline</json:string>
<json:string>natural product</json:string>
<json:string>trimethoprim analogue</json:string>
<json:string>less toxic</json:string>
<json:string>less effective</json:string>
<json:string>para position</json:string>
<json:string>fungal cell</json:string>
<json:string>unpublished datum</json:string>
<json:string>potent inhibitor</json:string>
<json:string>pyrimidine ring</json:string>
<json:string>aid epidemic</json:string>
<json:string>inosine analogue</json:string>
<json:string>mouse model</json:string>
<json:string>antipneumocystis agent</json:string>
<json:string>active site</json:string>
<json:string>naphthyl ring</json:string>
<json:string>paba incorporation</json:string>
<json:string>side chain</json:string>
<json:string>more effective</json:string>
<json:string>prophylaxis model</json:string>
<json:string>pyrimethamine analogue</json:string>
<json:string>human dihydrofolate reductase</json:string>
<json:string>inoculated mouse model</json:string>
<json:string>carinii topoisomerase</json:string>
<json:string>bartlett</json:string>
</teeft>
</keywords>
<author><json:item><name>QUEENER Sherry F.</name>
</json:item>
</author>
<arkIstex>ark:/67375/TPS-FLJ41GZ5-J</arkIstex>
<language><json:string>unknown</json:string>
</language>
<originalGenre><json:string>Article</json:string>
</originalGenre>
<qualityIndicators><score>7.012</score>
<pdfWordCount>16640</pdfWordCount>
<pdfCharCount>110298</pdfCharCount>
<pdfVersion>1.6</pdfVersion>
<pdfPageCount>21</pdfPageCount>
<pdfPageSize>615.84 x 801.6 pts</pdfPageSize>
<pdfWordsPerPage>792</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>false</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</title>
<genre><json:string>research-article</json:string>
</genre>
<host><title>Journal of Medicinal Chemistry</title>
<language><json:string>unknown</json:string>
</language>
<issn><json:string>0022-2623</json:string>
</issn>
<publisherId><json:string>jm</json:string>
</publisherId>
<volume>38</volume>
<issue>24</issue>
<pages><first>4739</first>
<last>4759</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<ark><json:string>ark:/67375/TPS-FLJ41GZ5-J</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - chemistry, medicinal</json:string>
</wos>
<scienceMetrix><json:string>1 - natural sciences</json:string>
<json:string>2 - chemistry</json:string>
<json:string>3 - medicinal & biomolecular chemistry</json:string>
</scienceMetrix>
<scopus><json:string>1 - Life Sciences</json:string>
<json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string>
<json:string>3 - Drug Discovery</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Medicine</json:string>
</scopus>
</categories>
<publicationDate>1995</publicationDate>
<doi><json:string>10.1021/jm00024a001</json:string>
</doi>
<id>5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/bundle.zip</uri>
</json:item>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/fulltext.txt</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</title>
<respStmt><resp>Références bibliographiques récupérées via GROBID</resp>
<name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name>
</respStmt>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>American Chemical Society</publisher>
<date type="e-published" when="2002-05-01">2002</date>
<date when="1995-11-01">1995</date>
</publicationStmt>
<notesStmt><note type="content-type" source="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note>
<note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</title>
<author xml:id="author-0000"><persName><surname>Queener</surname>
<forename type="first">Sherry F.</forename>
</persName>
</author>
<idno type="istex">5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22</idno>
<idno type="ark">ark:/67375/TPS-FLJ41GZ5-J</idno>
<idno type="DOI">10.1021/jm00024a001</idno>
</analytic>
<monogr><title level="j" type="main">Journal of Medicinal Chemistry</title>
<title level="j" type="abbrev">J. Med. Chem.</title>
<idno type="publisher-id">jm</idno>
<idno type="coden">jmcmar</idno>
<idno type="ISSN">0022-2623</idno>
<imprint><publisher>American Chemical Society</publisher>
<date type="e-published" when="2002-05-01">2002</date>
<date when="1995-11-01">1995</date>
<biblScope unit="vol">38</biblScope>
<biblScope unit="issue">24</biblScope>
<biblScope unit="page" from="4739">4739</biblScope>
<biblScope unit="page" to="4759">4759</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass ana="subject"><keywords scheme="document-type-name"><term>Article</term>
</keywords>
</textClass>
<langUsage><language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc><change xml:id="refBibs-istex" who="#ISTEX-API" when="2019-08-2">References added</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
</fulltext>
<metadata><istex:metadataXml wicri:clean="corpus acs not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:document><article specific-use="acs2jats-2.1.12" xml:lang="en" dtd-version="1.1"><front><journal-meta><journal-id journal-id-type="publisher-id">jm</journal-id>
<journal-id journal-id-type="coden">jmcmar</journal-id>
<journal-title-group><journal-title>Journal of Medicinal Chemistry</journal-title>
<abbrev-journal-title>J. Med. Chem.</abbrev-journal-title>
</journal-title-group>
<issn publication-format="print">0022-2623</issn>
<publisher><publisher-name>American Chemical Society</publisher-name>
</publisher>
<self-uri xlink:type="simple">pubs.acs.org/jmc</self-uri>
</journal-meta>
<article-meta><article-id pub-id-type="doi">10.1021/jm00024a001</article-id>
<article-categories><subj-group subj-group-type="document-type-name"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Queener</surname>
<given-names>Sherry F.</given-names>
</name>
</contrib>
</contrib-group>
<pub-date date-type="pub" publication-format="electronic"><day>1</day>
<month>05</month>
<year>2002</year>
</pub-date>
<pub-date date-type="issue-pub"><day>1</day>
<month>11</month>
<year>1995</year>
</pub-date>
<volume>38</volume>
<issue>24</issue>
<fpage>4739</fpage>
<lpage>4759</lpage>
<history></history>
<custom-meta-group><custom-meta xlink:type="simple"><meta-name>document-id-backfile</meta-name>
<meta-value>jm00024a001</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii</title>
</titleInfo>
<name type="personal"><namePart type="family">QUEENER</namePart>
<namePart type="given">Sherry F.</namePart>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>American Chemical Society</publisher>
<dateIssued encoding="w3cdtf">1995-11-01</dateIssued>
</originInfo>
<relatedItem type="host"><titleInfo><title>Journal of Medicinal Chemistry</title>
</titleInfo>
<titleInfo type="abbreviated"><title>J. Med. Chem.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">0022-2623</identifier>
<identifier type="PublisherID">jm</identifier>
<identifier type="coden">JMCMAR</identifier>
<identifier type="uri">pubs.acs.org/jmc</identifier>
<part><date>1995</date>
<detail type="volume"><caption>vol.</caption>
<number>38</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>24</number>
</detail>
<extent unit="pages"><start>4739</start>
<end>4759</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22</identifier>
<identifier type="ark">ark:/67375/TPS-FLJ41GZ5-J</identifier>
<identifier type="DOI">10.1021/jm00024a001</identifier>
<accessCondition type="use and reproduction" contentType="restricted">American Chemical Society. All rights reserved.</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-X5HBJWF8-J">ACS</recordContentSource>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-FLJ41GZ5-J/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C47 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002C47 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:5CB3BA1CDC8F7B7FFB8136F59B3D71D00ADB4A22
   |texte=   New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii

New Drug Developments for Opportunistic Infections in Immunosuppressed Patients: Pneumocystis carinii

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri